Available via license: CC BY 4.0
Content may be subject to copyright.
Program ACTIVE II: Design and Methods for a Multi-Center
Community-Based Depression Treatment for Rural and Urban
Adults with Type 2 Diabetes
Mary de Groot1,*, Jay Shubrook2, Frank Schwartz3, W. Guyton Hornsby Jr4, Yegan Pillay5,
and Chandan Saha1
1Indiana University School of Medicine, USA
2Touro University School of Medicine, USA
3Ohio University Heritage College of Osteopathic Medicine, USA
4West Virginia University School of Medicine, USA
5Ohio University, USA
Abstract
Objective—Depression affects one in four adults with type 2 diabetes (T2DM) and is associated
with worsened diabetes complications, increased health care costs and early mortality. Rural and
low-income urban areas, including the Appalachian region, represent an epicenter of the T2DM
epidemic. Program ACTIVE II is a comparative effectiveness treatment trial designed to test
whether a combination of cognitive behavioral therapy (CBT) and community-based exercise
(EXER) will offer greater improvements in diabetes and depression outcomes compared to
individual treatment approaches and usual care (UC). The secondary aims are to assess changes in
cardiovascular risk factors across groups and to conduct a cost-effectiveness analysis of predicted
incidence of cardiovascular complications across groups.
Methods—The study is a 2-by-2 factorial randomized controlled trial consisting of 4 treatment
groups: CBT alone, EXER alone, combination of CBT and EXER, and UC. Adults with T2DM
for > 1 year and who meet DSM-IVTR criteria for Major Depressive Disorder (MDD) are eligible
to participate at two rural Appalachian sites (southeastern Ohio and West Virginia) and one urban
site (Indianapolis). This type II behavioral translation study uses a community-engaged research
(CEnR) approach by incorporating community fitness centers and mental health practices as
interventionists.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
*Corresponding author: Mary de Groot, Ph.D., Associate Professor, Indiana University School of Medicine, 410 W. 10th St., Suite
1140, Indianapolis, IN 46202, USA, Tel: (317) 278-1965; Fax: (317) 278-1750; mdegroot@iu.edu.
Author Contributions
All authors (MdG, JS, FS, WGH, YP) contributed to the study design, writing the manuscript and reviewing and editing all portions of
the manuscript.
Dr. de Groot and the co-authors serve as the guarantors of the manuscript and take full responsibility for the work as a whole including
the study design, access to data and decision to submit and publish the manuscript.
HHS Public Access
Author manuscript
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Published in final edited form as:
J Diabetes Res Ther
. 2015 August ; 1(2): .
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Conclusions—This is the first study to evaluate the comparative effectiveness of combined CBT
and exercise in the treatment of depression using community-based intervention delivery. This
approach may serve as a national model for expanding depression treatment for patients with
T2DM.
Introduction
Nearly one in 10 Americans has diabetes and current projections estimate diabetes will
affect one in three Americans born in the year 2000 [1] resulting in annual T2DM-related
costs of $256 billion [2]. Low-income urban and rural areas such as the Appalachian region
bear a disproportionate burden of the national T2DM epidemic [3]. In West Virginia (WV),
the statewide age-adjustment prevalence of diagnosed T2DM is 10.4% [4] while the average
prevalence rate of T2DM in rural Appalachian Ohio (OH) counties is 11.3% [5] exceeding
the national average of 9.3% [1].The Appalachian region also bears a disproportionate
burden of major depressive disorder (MDD; 8.2%) compared to non-Appalachian areas
(7.6%), with higher rates found in central Appalachian states (10.6%) such as WV and OH
than northern or southern states [6].
Barriers to care for T2DM and MDD in low-income urban and rural areas such as central
Appalachia are considerable and similar. Decreased access to health and mental health care
providers, lack of public transportation and rising costs for private transportation (e.g. gas
prices) in the context of geographic isolation pose significant barriers to consistent and
effective health and mental health care [7–8]. Patients with T2DM have been found to be
two times more likely to experience depressive symptoms than their non-diabetic peers with
one in four patients reporting clinically significant depressive symptoms and 11.4% meeting
criteria for MDD [9].
Depressive symptoms have been shown to be associated with worsened blood glucose levels
[10] and T2DM complications [11]. In addition, significant functional and financial costs are
associated with depression and T2DM including decreased adherence to diabetes care
regimens[12], increased functional disability [13], increased health care costs without
resulting improvements in depression or diabetes outcomes [14], decreased quality of life
[15–16]and earlier mortality attributable to all causes (17–18).
Few controlled treatment trials have been conducted to treat depression and T2DM [19–23].
Only three have evaluated behavioral treatment strategies in this population. In a meta-
analysis of 29 randomized controlled trials evaluating cognitive behavioral therapy (CBT)
treatment for MDD across a continuum of disease states, a robust effect size (−.83)
documented the efficacy of this approach [24]. In a study of 51 patients
(meanage53+10years;60%female)diagnosedwithT2DM(meanduration 8 years) and MDD
randomly assigned to a 10-week individualized CBT or control condition without
medication intervention, Lustman found that patients receiving CBT were 3 times more
likely to experience depression remission at post-treatment assessment than controls [19].
Although no group differences in A1c levels were found at post-treatment assessment
(adjusted for baseline values), patients in the CBT condition showed improvement in A1c at
de Groot et al. Page 2
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
the 6-month follow-up assessment compared to controls [19]. Treatment responsiveness
appeared to be associated with severity of depression and A1c at baseline [19,25].
In the Pathways Study, problem-solving therapy (a variation of CBT) was integrated within
the primary care setting to treat depression in adults with T2DM [23]. Participants
randomized to a stepped-care problem-solving therapy intervention reported higher levels of
treatment exposure, satisfaction with care and improved depression outcomes compared to
patients in the usual care group. In this study, improvements in glycemic control were not
observed immediately following care or at 6- or 12-month follow-up assessments [23].Taken
together; these studies demonstrate the efficacy of CBT in treating depression in adults with
T2DMwith mixed results associated with changes in glycemic control.
Exercise has the potential to directly improve glycemic outcomes in the context of MDD
treatment and has been shown to be an efficacious treatment for clinical depression among
adults without T2DM [26–27]. In a meta-analysis of 37 exercise intervention trials in
clinically depressed samples, Craft & Landers [28]found a large overall effect size (−.72) in
the reduction of clinical depression with the greatest impact found in samples with
moderate-to-severe levels of depression. Exercise interventions of 9 to12 weeks showed
significantly greater impact on depression outcomes, but no differences were observed in the
types of exercise used in treatment protocols. Exercise interventions have also been shown to
improve glycemic control in patients with T2DM [29–34].
To date, only one randomized controlled trial (RCT) has examined the impact of exercise on
depression in adults with type 2 diabetes. Piette and colleagues randomized 291 adult
patients with T2DM and depressive symptoms (mild to severe) to 12 weeks of manualized
telephone-based CBT (with 9 monthly booster sessions) with a walking programor enhanced
UC [35]. At 12-month follow-up, 58% of participants in the intervention group had
depressive symptoms fall below the mild threshold. Number of steps was higher and systolic
blood pressure was lower in the intervention group at follow-up. No changes were observed
in A1c at the 12-month follow-up assessment [35]. The telephone-based CBT and walking
interventions were combined and could not be evaluated for depression and A1c outcomes
separately.
To date, the existing literature has utilized traditional randomized controlled trials that make
use of research or health care personnel to implement the interventions. No studies have
evaluated the comparative effectiveness of CBT and exercise by implementing these
interventions with community fitness and mental health providers using a community-
engaged research (CEnR) approach. The challenge for health care providers and
communities is to create depression treatment programs for T2DM patients that will reach
the largest number of people at the lowest possible cost and burden to health care
organizations. Program ACTIVE II has been designed to create a model program of
community-based depression treatment using a CEnR design that may be disseminated and
adopted nationally. Central to this model is the assumption that effective depression
treatment requires multiple avenues of access beyond the formal health care system and
multiple approaches to depression treatment such as CBT and exercise. Program ACTIVE II
has been designed to simultaneously achieve two overarching goals: 1) to test the
de Groot et al. Page 3
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
comparative effectiveness of the cognitive behavioral therapy (CBT) and community-based
exercise (EXER) to usual care (UC); and 2) to develop a sustainable program that may be
used as a scalable model for T2DM and depression treatment for national dissemination.
The research team has partnered with community mental health providers and exercise
facilities to implement the intervention. This paper reports on the innovative design and
methodology of this large-scale multi-site trial.
Research Design and Methods
Program ACTIVE II is a 2-by-2 factorial repeated measures RCT design. The study is a
multi-center trial in 3 states designed to maximize generalizability of the findings across
high risk groups in both urban and rural areas to assess outcomes and to build the
infrastructure necessary to achieve a sustainable program. Program ACTIVE II uses a
community-engaged research (CEnR) approach in which community organizations are
engaged in all aspects of the study: recruitment, intervention implementation, and
dissemination of findings. This approach confers additional validity to the study outcomes
by examining the effectiveness of the intervention in the sites where they are ultimately
designed to take place and demonstrated stakeholder commitment to the intervention which
serves as a foundation for the ultimate adoption of the Program ACTIVE intervention
beyond the period of federal funding.
The purpose of Program ACTIVE II is to address two primary aims: 1) to compare changes
in glycemic control across individual intervention groups to usual care (UC) at post-
intervention (POST) and 6- and 12-month follow-up assessments; and 2) to compare
changes in MDD outcomes across individual intervention groups to UCat POST and 6- and
12-month follow-up assessments. The study will also address two secondary aims: 1) to
compare changes in cardiovascular risk factors (e.g. LDL cholesterol) across individual
groups to UC at each of the 3 time points; and 2) to calculate the cost-effectiveness of each
treatment arm in terms of predicted incidence of cardiovascular complications over a 10-year
period.
Sample size
Based on our pilot study [36] and a meta-analysis by Boule et al., we used a conservative
assumption of a mean (SD) difference of 0.6% (1.4%) in improving A1c between the UC
and exercise groups at post intervention [29].Using a sample size of 43 in each of the four
treatment groups will have 80% power to detect the main effect of exercise. However, we
will recruit 54 per group assuming a 20% dropout rate.
In estimating the sample size to detect changes in MDD outcomes, we assumed 60% and
30% remission rates for the CBT and UC groups, respectively, at post intervention [19].
Using a sample size of 43 in each of the four treatment groups will have 97% power to
detect the main effect of CBT.
de Groot et al. Page 4
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Randomization
A site-specific computer generated randomization list was used to randomly assign study
subjects to one of the four treatment groups. A block size of four was used to ensure balance
in number of subjects recruited in four groups after recruiting every four subjects.
Characteristics
Inclusion/Exclusion Criteria—Inclusion criteria: age 18 or older, ambulatory status,
diagnosis of T2DM for one year duration or longer, major depression lasting 2 weeks or
longer with no evidence of psychotic symptoms. Medical exclusion criteria include: history
of diabetic ketoacidosis (DKA), continuous insulin therapy since T2DM diagnosis, stage 2
hypertension as defined by JNC VII, recent cardiac events (e.g. unstable angina, diagnosed
angina, PTCA, any cardiac intervention for CAD or tachydysrhythmias in the past 6
months), laser surgery for proliferative retinopathy in the past 6 months, history of stroke,
lower limb amputation, asensory peripheral neuropathy, aortic stenosis or other severe
valvular heart disease, atrial fibrillation, severe COPD (e.g., basal oxygen), class III or IV
heart failure or medical instability. Psychiatric exclusion criteria include: active suicidal
ideation or a history of suicide attempt, bipolar depression or history of psychotic disorder
and current substance abuse or dependence disorder. Participants who are currently
prescribed antidepressant medications for 6 weeks or longer and who meet diagnostic
criteria for major depression without psychotic features are included.
Participants who report the use of a current antidepressant medication for 5 weeks or less are
excluded or deferred for later screening after the 6-week period. Participants who are
currently receiving psychotherapy from a mental health provider for MDD are excluded.
Participants who are currently receiving only medication management from a psychiatrist
are included. Respondents who meet eligibility criteria are invited to participate in the
baseline screening assessment and referred to their local site PI.
Recruitment
Participants are recruited from communities served by the 3 intervention areas: Indianapolis,
southeastern Ohio/western West Virginia and north central West Virginia. Advertising takes
place via physician offices, newspapers, radio stations, community centers, partnering
community organizations and community events. In addition, patients of partner medical
practices are contacted by phone to receive information about the study and to inquire about
interest and eligibility (IU and WV). The recruitment flow chart is shown in Figure 1
(below).Individuals are screened by telephone by trained study staff to determine initial
eligibility. Once eligible via phone screen, participants are scheduled for a baseline
assessment visit where the informed consent takes place. Medical and psychiatric data from
the baseline assessment are reviewed by the study or site medical directors (JS. FS, KF,
KM), exercise physiologist (GH) and PI (MdG) as a group to determine eligibility for study
enrollment. Eligible participants are then randomly assigned to one of the four groups: CBT,
EXER, CBT+EXER or UC.
de Groot et al. Page 5
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Assessment procedures
Psychological, behavioral and physiologic measures are administered at each assessment
period: baseline, post-intervention, 6- and 12-month follow-up with the exception of
demographic characteristics (baseline only). Measures are shown in Table 1.
At the beginning of the baseline assessment visit, individuals are consented to participate in
the study by the Site PI or project coordinator. Baseline assessment includes the medical
history interview, blood draws, anthropometric measurements and fitness assessment.
Participants are given a pedometer, food and activity diaries and questionnaires to complete
following the baseline assessment. Participants complete psychosocial measures at home
(returned by mail) and complete a SCID Axis I interview by phone. The core investigator
team, site PIs and project coordinators conduct weekly teleconferences to review all data
following baseline assessment. Participants who meet all study criteria are randomized to
one of the four intervention groups, scheduled for a free nutritional education program and
their first intervention session (CBT, EXER or CBT+EXER) the following week.
Interventions
The active interventions in Program ACTIVE II are 12-weeks of community-based exercise
and 10 individual sessions of CBT. In order to facilitate diabetes education and to offer an
incentive to UC participants,
Dining with Diabetes
nutrition classes are provided to
participants in all arms. Based on prior studies, nutrition education is not expected to
influence depression outcomes [19].
CBT Intervention—CBT has gained wide acceptance as an efficacious intervention
approach for the treatment of depression [50]. CBT posits that cognitions, emotions and
behaviors are interwoven and mutually reinforcing in the depressed patient [50]. Treatment
involves the identification and reframing of “automatic thoughts” (i.e., cognitive biases) that
work in the service of depressogenic core cognitive beliefs [50]. Cognitive biases and core
beliefs are empirically tested and restructured. Behavioral techniques, such as increasing
daily activity and development and interaction with social support networks are interwoven
into CBT therapy [50]. The use of cognitive and behavioral tools modeled in therapy and
generalized by the participant through take home activities provides participants with an
opportunity to generalize skills to situations beyond the therapeutic relationship.
CBT sessions are conducted by trained licensed mental health providers currently in practice
in their respective communities. They represent the range of practice environments from
individual private practitioners to community mental health centers. Participants receive 10
sessions of CBT using the manualized approach based on Beck’s model of cognitive therapy
[50].Sessions are scheduled weekly over the course of the 12-week period. In light of the
large array of skills that are possible to include in the CBT framework, selected goals have
been targeted for our brief therapy format (presentation of CBT model; thought records,
cognitive distortions, counterarguments, cognitive reframing, automatic thoughts, core
beliefs, and relapse prevention). CBT therapists receive training in CBT and manualized
training approach from the study team.
de Groot et al. Page 6
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Exercise Intervention—The exercise protocol is a community-based exercise
intervention based on the aerobic exercise goals adapted from the Lifestyle Balance behavior
arm of the DPP [44]. Partner exercise facilities represent a range of fitness facilities
including physical therapy practices, community centers and for-profit and non-profit fitness
organizations (e.g. YMCA). Trained instructors at each facility provide 6 classes of
monitored instruction on exercise to participants to meet heart rate and activity-level goals.
Membership to the centers is provided to participants free of cost throughout the 12-week
intervention period. Passes to fitness facilities and costs for time spent with the fitness
trainer are purchased by the grant to increase access to exercise for the duration of the
protocol. These costs replicate costs of the program to community members of an
independent program.
Exercise goals are adapted to accommodate the physical and medical restrictions of an
older-adult T2DM population. Exercise prescriptions are based on the results obtained from
the baseline 6MWT. Participants are given exercise goals of performing 150 minutes per
week of moderate activity at 40- <60% of heart rate reserve (HRR), comparable to a Rating
of Perceived Exertion of 11–13. These goals may be modified based on results of the 6
Minute Walk Test (6MWT). Due to high rates of sedentary behaviors in this population,
physical activity goals are increased in a graduated fashion during Weeks 1–3, beginning
with 100 minutes of weekly aerobic exercise to 150 minutes of total aerobic weekly exercise
by Weeks 4–12 [47]. Intensity of activity begins at 40% in Week 1 and progresses as
tolerated, but continues to remain below 60% of HRR.
In order to provide participants with the necessary training to begin a safe exercise program,
exercise classes are taught by trained fitness instructors at each exercise site in Weeks 1–4
and again in Weeks 6 and 8. In Week 1, participants are introduced to the proper use of
exercise equipment and the exercise prescriptions. During these sessions, participants are
monitored for 50-minutes of exercise by the exercise fitness instructor. Participants are
trained to exercise in a manner consistent with ACSM recommendations including 10
minutes of pre-activity (warm-up and stretching), 30 minutes of active exercise (endurance),
and 10 minutes of post-activity (cool down, recovery) [47,51]. Participants receive feedback
throughout the 50-minute session on their intensity for each given activity. Heart rate and
blood pressure are measured at rest, at peak activity level, and following recovery.
Participants are trained to utilize the Borg Scale [52] during their activity to monitor exercise
intensity.
In Weeks 2–4, participants are given personalized instruction on exercise modes available
including walking on a track, use of treadmills and stationary recumbent/upright ergometers
consistent with the equipment of each fitness location. In weeks 6 and 8, participants attend
an in-person booster session at their local exercise center to re-establish the appropriate
exercise intensity and assess exercise technique. Exercise prescriptions may be adjusted at
this time based on the information obtained about exercise intensity. At each class, a chapter
from the Program ACTIVE II Exercise Manual is provided to participants. Adapted from the
DPP Lifestyle Balance intervention materials, the manual is designed to address
psychological barriers associated with physical activity (e.g. social support, motivation,
behavioral goals).
de Groot et al. Page 7
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Participants are asked to complete weekly exercise diaries and to record number of steps
measured using pedometers provided by the study (Weeks 1–12) on paper or in electronic
form through the website. Participants are contacted bi-weekly by a member of the study
team to review information from activity diaries and pedometers and to evaluate any
exercise-related medical concerns including: hyperglycemia, hypoglycemia, joint pain, back
pain, angina, lightheadedness, and symptoms of hypotension. Data from participants who
report medical symptoms resulting from exercise will be shared with the Medical Director
for the respective site. The development of severe adverse events is communicated to the site
Medical Director, Data Safety and Monitoring Panel and hosting IRB offices for
consultation. SMBG data is downloaded electronically to examine significant changes in
daily blood sugars as a result of exercise. Participants who show increased instances of
hyper- or hypoglycemia are contacted by the project coordinator and advised to contact their
primary care provider for assessment of medications. Participants are provided with
electronic (via website) and paper (as needed) supplemental adherence materials (i.e. toolkit)
such as walking maps, self-care information, and games to promote adherence.
Nutrition Intervention—In order to evaluate the effectiveness of the target interventions
in the context of T2DM treatment best practices, participants in all 4 groups are provided
classes in the Dining with Diabetes (DWD) program through The Ohio State University,
West Virginia University Extension or Purdue University Marion County Extension.
Statistical analyses
The intention-to-treat principle will be used for all analyses. Differences in participants’
baseline characteristics among 4 groups will be evaluated by ANOVA or the nonparametric
Kruskal-Wallis test for continuous outcomes and by Chi-square test for categorical
outcomes. A mixed-model analysis of variance including site, treatment group, time, gender,
race, age, baseline value of A1c will be used to assess the effects of exercise on A1c at post-
intervention, 6- and 12-month. Participants will be treated as a random effect and a un-
structure covariance matrix will be used. The dichotomous primary outcome, remission in
depression, will be analyzed by a non-linear mixed-effects model and will adjust for
potential confounder’s gender, race, age and baseline depression score. In each of the above
two models, an interaction effect between time and treatment group will be assessed first. If
there is no interaction effect, the overall treatment difference will be assessed. Otherwise,
treatment difference will be assessed at each time point. The model will be fitted by the SAS
procedure NLMIXED.
Secondary Outcomes
Functional exercise status and cardiovascular risk factors
A repeated measures ANCOVA will be conducted to assess changes in highest HR during
the 6 minute walk test, distance achieved, LDL-C, HDL-C, triglycerides, and resting blood
pressure from baseline to POST and baseline to the 6- and 12-month assessments.
de Groot et al. Page 8
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Cost-effectiveness (CE) analyses
A Markov decision model of type 2 diabetes progression to complications will be
constructed using cost data collected at baseline, post-intervention, 6 and 12 months of
follow-up. Short- and long-term effects of the intervention can be estimated by including
time horizons 3, 10, 20 and lifetime in the Markov model. All costs will be adjusted to the
year 2007 using the US Consumer Price Index.
Markov models
We will develop a Markov decision model with sensitivity analyses to estimate the
Incremental Cost-Effectiveness ratio (ICER) of the intervention compared to UC as
implemented in Program ACTIVE II. An ICER is computed by the ratio of ΔC/ΔE where
ΔC represents the change in cost due to the intervention compared with UC and ΔE
represents the change in health benefits due to the intervention compared with UC. We will
use TreeAge Pro Suite 2009 software (TreeAge Software, Williamstown, MA). The model
will directly incorporate intervention effectiveness and cost data as well as event
probabilities from the RCT to estimate life expectancy, quality-adjusted life-expectancy
(expressed as QALYs), clinical outcomes (diabetes complications), and direct medical and
nonmedical costs associated with the interventions and UC.
Data Safety and Monitoring Panel
A Data Safety and Monitoring Panel (DSMP) were created to provide expert consultation in
the primary disciplines involved in the content of the study: psychology, medicine, and
exercise physiology. These consultants provide input on issues such as metabolic or
physiological changes in participants during participation, mental status of participants, and
implementation of the exercise protocol throughout Program ACTIVE II. Members of the
panel are available for consultation for issues of research ethics, clinical care, and human
subject’s protection. Members of the panel are independent from the research team to ensure
objectivity in the treatment of participants.
Data integrity is reviewed by the Core Investigators in consultation with Dr. Chandan Saha
of the IUSM Department of Biostatistics. The Core Investigators meet monthly by phone to
discuss issues related to recruitment, implementation of the intervention, participant safety,
and to monitor data trends (e.g., adherence, missing data.
Conclusions
T2DM and co-morbid depression represents a growing challenge to patients and health care
systems as the prevalence of both disorders rises but access to treatment remains limited. In
this study, we are investigating the comparative effectiveness of a combination of CBT and
exercise using a CErN approach in which community fitness and mental health partners
provide depression treatment to study participants. This approach is novel because it is the
first study to examine the comparative effectiveness of two behavioral treatment approaches
to depression and T2DM. Moreover, it leverages community resources such as fitness
centers, community centers and community mental health professionals that already exist in
rural and low-income urban communities to serve as treatment partners to health care
de Groot et al. Page 9
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
centers. At the same time, it expands knowledge of diabetes treatment issues to these
community providers thereby expanding continuity of care for participants.
Data from this study will provide the empirical foundation for community stakeholders to
evaluate the value of this program in terms of health and mental health outcomes in their
communities and to identify the ways that this may become a sustainable treatment resource
for communities beyond the period of federal funding. Lessons learned from this study will
also inform the dissemination of this intervention as a model that may be scaled to the
national level to alleviate the burden and costs with this important set of disorders.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
Program ACTIVE II was funded by the National Institute of Diabetes, Digestive Disease & Kidneys
(R18DK092765 & R34DK071545). The Program ACTIVE Research Team wishes to thank the following
individuals for their many contributions to this study: Barb Myers, B.S., CCRP; Rachel Clift, RN; Susan Eason,
M.A.; David Donley, M.S.; Lindsey Sams, B.S.; Jaclyn Babe, B.S.; Christiaan Abildso, Ph.D; Daniel Bonner, M.S.,
Melinda Ruberg, B.S.; Bernadette Heckman, Ph.D.; CammieStarner; Lynn Petrik; Tracey Garrett; Chelsea Holbert,
M.A.; Debby Wimer; Kelly Chaudoin, M.A.; Sarah Mielens, M.A.; Ellen Knapp, M.A.; Kent Crick, B.S.; Danielle
Epler, M.S.; Michelle Weinstein, M.S.; Kasey Goodpaster, Ph.D.; Brett McKinney; KishaWilkerson.
We also wish to acknowledge our community partners who delivered interventions to our participants: Hopewell
Health Center, Belpre and Athens, OH; Marietta Family YMCA, Marietta, OH; Sharon Sheets, Athens, OH; Jason
Weber, Athens, OH; Sheila Williams, Athens, OH; Counseling & Wellness Center, Parkersburg, WV; Mountain
River Physical Therapy, Parkersburg and Vienna, WV; Family Fitness, Parkersburg, WV; Wellworks, Athens, OH;
Athens Community Center, Athens, OH; West Virginia University County Extension Program; The Ohio State
University Washington County Extension Program; Purdue University Marion County Extension Program; United
Summit Center, Clarksburg, WV;., Kimberly Yingling, M.A., NCC, LPC, Morgantown, WV; Tygart Valley
Rehabilitation and Fitness Center, Grafton, WV; Fairmont General HealthPlus, Fairmont, WV; Pro Performance,
Morgantown, WV; Rob’s Fitness Factory, Morgantown, WV;, Harrison County YMCA, Lodgeville Branch,
Bridgeport, WV; Midtown Community Mental Health, Indianapolis, IN; YMCA of Greater Indianapolis,
Indianapolis, IN; Physically Active Residential Communities and Schools (PARCS) Program, Indianapolis, IN;
Chase Near Eastside Legacy Center, Indianapolis, IN; Natalie Johann; Denise Sayasit; Evan Heald; Latisha
Idlewine; Julie Kenny; Matt Larson; Gary Brown; Chelsy Winters; Anne Graves; Christina Ferroli; Lydia
Armstrong; LaRona Dixon; Allison Plopper; Ben Jones; James Brummett; Kathi Bledsoe; Allison White; Ella
Vinvi; Cynthia Donel; Monica Staples; Tina Wiesert; Carol Hendricks; Cindy Wilson; Richard Nulter; Kim
Johnson, M.A.; Adryanne Garrett; Bonnie de Lange; Cassandra Watt; Priscilla Leavitt, Ph.D.; Rick Stanley, Ph.D.;
Stephen Givens, Psy.D.; Sharon Sheets, M.A.; Suzy Zumwalde; Dave Vogel; Noah Albrecht; Joe Leaman; Erin
Weber; Allison Burner; Dan Braatz; CassyOffenberger; Eric Weber; Jonathan Rodriquez; Pat Perine; Louie Haer;
Josh Christen; McKenzie Walter; Flynt Smathers; Rich Campitelli; Kathy Dodrill; Brian Sharp, Ph.D.; Dana
Nugent, Psy.D; Mark Tipton, M.A., A.A.D.C, LPC; Eric Shaw, M.P.T; Rick Williams, C.D.M., M.P.F.T; Shane
Trivigno, B.S.; Kellie Snyder, B.S., M.B.A, C.P.T; Beth Burleson, B.S. C.P.T; Brad Wright, B.S, C.P.T; Rob Cress
M.S., C.S.C.S; Jesse Halldin, B.A, CPT; Whitney Hickman, B.S., A.C.S.M; Karen Newton, B.A; Eric Murphy,
M.S, M.A; Jennifer Murray, M.S; Lauren Prinzo, M.P.A; Rebecca Smith, M.B.A.
We thank all of the participants of Program ACTIVE who gave generously of their time and energy to engage in a
new research activity. We are grateful for their generosity of spirit and their willingness to try something new.
References
1. Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for
Disease Control and Prevention, US Department of Health and Human Services; 2012.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care.
2013; 36:1033–46. [PubMed: 23468086]
de Groot et al. Page 10
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
3. Weng C, Coppini DV, Sönksen PH. Geographic and social factors are related to increased morbidity
and mortality rates in diabetic patients. Diabet Med. 2001; 17:612–617. [PubMed: 11073184]
4. Centers for Disease Control and Prevention Centers for Disease Control and Prevention. National
Diabetes Surveillance System.
5. Schwartz F, Ruhil AV, Denham S, Shubrook J, Simpson C. High self-reported prevalence of diabetes
mellitus, heart disease and stroke in eleven counties in rural Appalachian Ohio. J Rural Health.
2009; 25:225–229.
6. National Opinion Research Center. An analysis of mental health and substance abuse disparities &
access to treatment services in the Appalachian region. 2008.
7. Arcury TA, Gesler WM, Preisser JS, Sherman J, Spencer J, et al. The effects of geography and
spatial behavior on health care utilization among the residents of a rural region. Health Services
Research. 2005; 40:135–55. [PubMed: 15663706]
8. Arcury TA, Preisser JS, Gesler WM, Powers JM. Access to transportation and health care utilization
in a rural region. J Rural Health. 2005; 21:31–38. [PubMed: 15667007]
9. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in
adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24:1069–78. [PubMed: 11375373]
10. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, et al. Depression and poor
glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000; 23:934–42.
[PubMed: 10895843]
11. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and
diabetes complications: a meta-analysis. Psychosom Med. 2001; 63:619–30. [PubMed: 11485116]
12. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms
on adherence, function, and costs. Arch Intern Med. 2000; 160:3278–3285. [PubMed: 11088090]
13. Egede L. Major depression in individuals with chronic medical disorders: prevalence, correlates
and association with health resource utilization, lost productivity and functional disability. Gen
Hosp Psychiatry. 2007; 29:409–16. [PubMed: 17888807]
14. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use
and expenditures in individuals with diabetes. Diabetes Care. 2002; 25:464–470. [PubMed:
11874931]
15. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression and quality of life. A
population study. Diabetes Care. 2004; 27:1066–70. [PubMed: 15111522]
16. Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on
quality of life in patients with type I and type II diabetes mellitus. Qual Life Res. 1997; 6:11–20.
[PubMed: 9062437]
17. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E. The association of comorbid depression with
mortality in patients with type 2 diabetes. Diabetes Care. 2005; 28:2668–2672. [PubMed:
16249537]
18. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, et al. Depressive symptoms and mortality
among persons with and without diabetes. Am J Epidemiol. 2005; 161:652–660. [PubMed:
15781954]
19. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for
depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;
129:613–21. [PubMed: 9786808]
20. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, et al. Effects of nortriptyline on
depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.
Psychosom Med. 1997; 59:241–50. [PubMed: 9178335]
21. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a
randomized double-blind placebo-controlled trial. Diabetes Care. 2000; 23:618–23. [PubMed:
10834419]
22. Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB. Sertraline in coexisting major
depression and diabetes mellitus. Psychopharmacol Bull. 1997; 33:261–264. [PubMed: 9230640]
23. Katon W, von Korff M, Ciechanowski P, Russo J, Lin E, et al. Behavioral and clinical factors
associated with depression among individuals with diabetes. Diabetes Care. 2004; 27:914–20.
[PubMed: 15047648]
de Groot et al. Page 11
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
24. Beltman MW, Voshaar RC, Speckens AE. Cognitive behavioral therapy for depression in people
with somatic disease: meta-analyis of randomized controlled trials. Br J Psychiatry. 2010; 197:11–
19. [PubMed: 20592427]
25. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Predicting response to cognitive behavior
therapy of depression in type 2 diabetes. Gen Hosp Psychiatry. 1998; 20:302–6. [PubMed:
9788030]
26. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S. Effects of exercise training on
older patients with major depression. Arch Intern Med. 1999; 159:2349–2356. [PubMed:
10547175]
27. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M. Exercise treatment for major
depression: Maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000; 62:633–638.
[PubMed: 11020092]
28. Craft LL, Landers DM. The effect of exercise on clinical depression and depression resulting from
mental illness: a meta-analysis. J Sport Exer Psychol. 1998; 20:339–57.
29. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glyemic control and
body mass index in type 2 diabetes: A meta-analysis of controlled clinical trials. JAMA. 2001;
286:1218–1227. [PubMed: 11559268]
30. Kirk A, Mutrie N, MacIntyre P, Fisher M. Effects of a 12-month physical activity counseling
intervention on glycemic control and on the status of cardiovascular risk factors in people with
type 2 diabetes. Diabetologia. 2004; 47:821–32. [PubMed: 15138687]
31. Mourier A, Gautier JF, De Kerviler E, Bigard AX, Villette JM. Mobilization of visceral adipose
tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM.
Diabetes Care. 1997; 20:385–91. [PubMed: 9051392]
32. Raz I, Hauser E, Bursztyn M. Moderate exercise improves glucose metabolism in uncontrolled
elderly patients with non-insulin dependent diabetes mellitus. Isr J Med Sci. 1994; 30:766–70.
[PubMed: 7960690]
33. Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A. Validation of a counseling strategy to
promote adoption and the maintenance of physical activity by Type 2 diabetes subjects. Diabetes
Care. 2003; 26:404–8. [PubMed: 12547870]
34. Kahn EB, Ramsey LT, Brownson RC, Heath GW, Howze EH. The effectiveness of interventions to
increase physical activity. Am J Prev Med. 2002; 22:73–107. [PubMed: 11985936]
35. Piette JD, Richardson C, Himle J, Duffy S, Torres T. A randomized trial of telephone counseling
plus walking for depressed diabetes patients. Med Care. 2011; 49:641–8. [PubMed: 21478777]
36. de Groot M, Doyle T, Kushnick M, Shubrook J, Merrill J. Can lifestyle interventions do more than
reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and
Cognitive Behavioral Therapy. Curr Diab Rep. 2012; 12:157–66. [PubMed: 22350739]
37. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R
(SCID) - I: History, rationale, and description. Arch Gen Psychiatry. 1992; 49:624–629. [PubMed:
1637252]
38. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, et al. The Structured Clinical Interview
for DSM-III-R (SCID) - II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992; 49:630–
636. [PubMed: 1637253]
39. Beck, AT.; Steer, RA.; Brown, GK. BDI-II Beck Depression Inventory Manual. 2. San Antonio,
TX: The Psychological Corporation. Harcourt, Brace & Company; 1996.
40. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in
diabetes using the Beck Depression Inventory. Psychosom Med. 1997; 59:24–31. [PubMed:
9021863]
41. Ware, J.; Snow, K.; Kosinski, M.; Gandek, B. The MOS SF-12 Health Survey: Manual and
Interpretation Guide. Vol. 1993. Boston, MA: The Health Institute, New England Medical Center;
1993.
42. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, et al. Functional status and well-being
of patients with chronic conditions. JAMA. 1989; 262:907–913. [PubMed: 2754790]
43. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl
Sport Sci. 1985; 10:141–6. [PubMed: 4053261]
de Groot et al. Page 12
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
44. Diabetes Prevention Program. Diabetes Prevention Program Lifestyle Balance Core Manual.
Pittsburgh, PA: University of Pittsburgh; 1996.
45. Bassett DR, Ainsworth BE, Swartz AM, Strath SJ, O’Brien WL, et al. Validity of four motion
sensors in measuring moderate intensity physical activity. Medical Science Sports Exercise. 2000;
32:S471–80.
46. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir
Cirt Care Med. 2002; 166:111–117.
47. Albright A, Franz M, Hornsby G, Kriska A, Marrero D, et al. American College of Sports
Medicine position stand on exercise and type 2 diabetes. Med Sci Sports Exerc. 2000; 32:1345–
1360. [PubMed: 10912903]
48. Executive Panel. Executive summary of the clinical guidelines on the identification, evaluation and
treatment of overweight and obesity in adults. Arch Intern Med. 1998; 158:1855–67. [PubMed:
9759681]
49. Noble BJ, Borg GA, Jacobs I, Ceci R, Kaiser P. A category-ratio perceived exertion scale:
relationship to blood and muscle lactates and heart rate. MSSE. 1983; 15:523–8.
50. Beck, JS. Cognitive therapy: basics and beyond. New York, NY: Guilford Press; 1995.
51. Mazzeo RS, Tanaka H. Exercise prescription for the elderly. Sports Med. 2001; 31:809–18.
[PubMed: 11583105]
52. Borg, G. Borg’s Perceived Exertion and Pain Scales. Vol. 1998. Champaign, IL: Human Kinetics;
1998.
de Groot et al. Page 13
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Figure 1.
Recruitment Flow Chart
Separate randomization lists were generated by the study statistician for use by each study
site.
de Groot et al. Page 14
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
de Groot et al. Page 15
Table 1
Administration of Assessment Measures in Program ACTIVE
Measures Screening Baseline POST 6- and 12- Mo.
Follow-Up Outcome Variable Covariate Clinical Monitoring Variable
Psychosocial
Demographic Characteristics XX
Structured Clinical Interview for the DSM-IVTR (SCID Axis
I Disorders) X (Screener) X X X Primary
Lifetime Current Current
Beck Depression Inventory (BDI) X X X Primary
Diabetes Quality of Life (DQOL) X X X Secondary
SF-36 Quality of Life Measure X X X Secondary
Chronic Illness Resource Survey (CIRS) X X X Secondary
Behavioral
Physical Activity Diary (1 week) X X X X
Pedometer (1 week) X X X X
Physiologic
Glycated Hemoglobin (A1c) X X X Primary
Blood lipid profile (HDL-C; triglycerides) X X X Secondary
Self-Monitored Blood Glucose (SMBG) X X X X
Medical History Interview X X
Medical Status Review X X X
6-Minute Walk Test X X X Secondary
Height X X X X
Weight X X X X
Waist/Hip Girth X X X
Blood Pressure X X X Secondary X
Resting Heart Rate/Pulse X X X X
Perceived Exertion (Borg rating) X X X X
J Diabetes Res Ther
. Author manuscript; available in PMC 2016 August 04.